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Retrospective study aiming at evaluating the interference of associate diseases in the evolution 
and prognosis of idiopathic sudden sensorineural hearing loss. 
Materials and methods: Case-Control Study. Thirty-five patients with idiopathic sudden sensorineural 
hearing loss were divided in two groups, one of them with associate diseases (hypertension, diabetes 
mellitus and dyslipidemias), and another one without co-occurrence of such diseases. The groups 
were evaluated regarding: age, gender, associate diseases, presence of tinnitus, dizziness and ear 
fullness sensation, presence of cerebral microangiopathy observed in magnetic resonance imaging, 
ophthalmoscopic findings, treatment onset, improvements in audiometric findings and at speech 
discrimination tests. Statistical analysis of data was performed. 
Results: The associate disease group showed higher ages, cerebral microangiopathy observed 
in magnetic resonance imaging and later improvement in speech discrimination tests, being this 
difference statistically significant. 
Conclusion: Idiopathic sudden sensorineural hearing loss co-occurring with hypertension, diabetes 
mellitus or dyslipidemias, in older patients, is associated with a higher prevalence of cerebral 
microangiopathy, revealed by magnetic resonance imaging, and associated with a slower hearing 
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INTRODUCTION
Hearing loss is one of the most common complaints 
in ENT offices today; however, it is still challenging. The 
evaluation of patients with proven hearing loss, especially 
when the loss is sudden, must be detailed, trying to iden-
tify possible associated causes and symptoms, as well as 
treatment, which should be instated as soon as possible. 
The name sudden hearing loss is already establi-
shed, but unfortunately it is a very inaccurate and vague 
term, often times being interpreted as a nosological entity 
instead of simply a symptom. That is the reason why we 
prefer to use the term sudden sensorineural hearing loss. 
We define sudden sensorineural hearing loss as 
being a sensorineural hearing loss above 30dB in at least 
three adjacent frequencies and of sudden onset or in up 
to 72 hours1. 
Etiology, as well as any other symptoms must be 
investigated systematically, since many diseases may 
be involved. Neoplasias, vascular alterations, immune-
mediated disorders, Meniere’s disease, membrane rupture 
and infectious diseases - viral or bacterial in origin, seem 
to be implicated2. Nonetheless, often times, the etiologi-
cal diagnosis is not possible even with the tests available 
today. In this case, the sudden sensorineural hearing loss 
is classified as idiopathic. 
The role of viral infections has been challenged. 
Studies have found cochlear alterations in temporal bones 
of patients with sudden hearing loss, similar to the ones 
associated with viral infections or even a larger presence 
of virus in the nasopharyngeal material in patients with 
sudden hearing loss3,4. These findings would suggest viral 
etiology for the sudden hearing loss, nonetheless, so far, 
we have been unable to confirm the clinical diagnosis 
in these findings, since it would be necessary to have 
histopathology studies of the temporal bone - which is 
not feasible in vivo, and the search for virus in the inner 
ear - which is not yet systematized. Concurrently, other 
authors found evidence that the viral infection would not 
be the cause of the sudden hearing loss5. 
In the treatment approach of the patients, althou-
gh with very little support in the literature, steroids are 
most used. In their study, Wilson6 noticed a significant 
improvement in those patients who used steroids instead 
of placebo, and such evidence has not been confirmed 
through a systematic review of the literature7. Anyway, 
treatment must be instated as soon as possible, with the 
best results being seen in up to seven days8. 
In the assessment of patients with sensorineural 
hearing loss, systemic disorders, especially systemic hyper-
tension, diabetes mellitus and dyslipidemias are directly or 
indirectly implicated, since there is no consensus of this 
association regarding sudden sensorineural hearing loss. 
Penido et al.1 observed during follow up of their 
patients with sudden sensorineural hearing loss that the 
worst results in treatment happened to older patients 
and those who had associated disorders: systemic arte-
rial hypertension, diabetes mellitus and dyslipidemias. 
However it did not differentiate whether these associated 
diseases and age were factors which had an isolated or 
joint impact in the evolution of these patients. 
The assessment of the role these associated di-
seases play is very important in order to have a better 
understanding regarding prognosis as well as a program 
for a better treatment strategy regarding the patients with 
sudden idiopathic sensorineural hearing loss. 
METHOD
We did a case-controlled study with the patients 
being followed in the sudden hearing loss ward between 
2000 and 2007. 
The project was evaluated and approved by the 
Ethics in Research Committee of the Institution, registered 
under No. 1871/06. 
Of the 177 patients diagnosed with sudden sen-
sorineural hearing loss, 95 were males and 82 females. 
After the investigation, 13 patients (7.35%) had a defined 
etiological diagnosis. The remaining 164 patients (92.65%) 
were classified as having sudden idiopathic sensorineural 
hearing loss. 
Of these 164 patients, we selected 35 individuals 
(21.34%) to participate in the study. The other patients 
did not fit the inclusion criteria and were, therefore, taken 
off the study. 
The inclusion criteria we adopted were:
- idiopathic sensorineural hearing loss of sudden 
onset, or installed in up to 72 hours, seen at the otology 
department before 30 days after symptom onset. 
- follow up at the sudden hearing loss ward for at 
least six months. 
The exclusion criteria we used were:
- Etiological study of the established hearing loss. 
- Use of prior treatment. 
- Systemic disorders other than systemic arterial 
hypertension, diabetes mellitus and dyslipidemias, already 
known or identified during follow up. 
- Follow up interruption. 
For evaluation purposes, the selected patients were 
broken down in two groups: group with associated disease 
and group without associated disease. 
- Group with associated disease: made up of pa-
tients with sudden idiopathic sensorineural hearing loss 
associated with systemic arterial hypertension, diabetes 
mellitus and dyslipidemias, alone or associated. 
- Group without associated disease: made up of 
patients with sudden idiopathic sensorineural hearing loss 
without the presence of associated diseases. 
The patients seen in the hearing loss ward went 
365
Brazilian Journal of otorhinolaryngology 76 (3) May/June 2010
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
through a general medical interview and complete physi-
cal exam. In this interview, the patients were asked about 
symptoms such as tinnitus, dizziness and full ear, as well 
as hearing loss duration. 
The treatment used in all the patients was made up 
of prednisone in the dose of 1mg/kg/day, for at least seven 
days, with a progressive dose reduction, and pentoxifylline 
in the dose of 1,200mg divided in three doses, maintained 
for at least eight weeks. 
The patients were submitted to magnetic resonance 
tests in their right ears, using gadolinium as a contrast 
medium, and blood tests: CBC, fasting glycemia, creati-
nine, total cholesterol and fractions, triglycerides, dosage 
of free T4. 
The hearing assessment of the patients was carried 
out by a MAICO MA-41 audiometer and all the tests were 
carried out by the same speech and hearing therapist. We 
also assessed initial audiometric patterns, after one month 
of treatment and that again six months after treatment or 
later. The auditory evaluation was made up of tonal au-
diometry, vocal audiometry with speech recognition index 
(SRI) and immittance measures with stapes reflexes study. 
The fundus of the eye test was always carried out 
by the same ophthalmologist. The alterations were clas-
sified according to the ETDRS (Early Treatment Diabetic 
Retinopathy Study) classification. 
In the anamneses of the diabetic patients with arte-
rial hypertension or dyslipidemias, the patients were also 
investigated about the duration of the disease and also 
treatment instated. Also regarding the diabetic patients, 
we carried out a tactile and thermal sensitivity evaluation, 
studying the presence of peripheral neuropathy. 
The auditory recovery assessment was carried out 
by means of an improvement rate, which measures the au-
ditory gain in percentage and uses the contralateral side as 
reference. Calculated according to the following formula:
Improvement rate (%) = (initial threshold - final 
threshold x 100 /initial threshold  - Contralateral ear 
threshold)
The auditory thresholds were calculated using the 
mean values of frequencies 50, 500, 1000, 2000, 4000, 
6000 and 8000 Hz. 
The threshold was obtained based on the last audio-
metry held in at least six months after treatment onset, and 
in all the cases the auditory thresholds of the contralateral 
ear were below 30dB. 
The variables analyzed in our study were: age, gen-
der, associated disease, tinnitus, dizziness and ear fullness, 
the presence of cerebral microangiopathy seen at the MRI, 
alterations in the fundus of the eye exam, treatment on-
set, hearing improvement rate, initial speech recognition 
index (SRI), after fifteen days, one month and six months 
or more of follow up. 
The results obtained were taken to statistical analy-
sis. In order to compare the two groups studied regarding 
the categorical variables belonging to the study, we used 
the Fisher’s exact test. Regarding variables age, improve-
ment rate and treatment onset we used the t Student test 
for unrelated samples; and in order to study the behavior 
of the SRI variable in time for each group, we used the 
variance analysis model with repeated measures. 
In all the analysis, the significance level was 5% 
(p<0.05).
RESULTS
The analysis was initially made up of a general 
discussion of the information collected. The gender dis-
tribution in the two groups was similar. The group with 
associated disease was made up by ten men and ten wo-
men and the group without associated disease by seven 
men and eight women. 
Table 1 depicts the mean values of age, impro-
vement rate and time of treatment onset of the sudden 
sensorineural hearing loss in the two groups, with their 
respective standard deviation and maximum and minimum 
values. 
Table 1. Descriptive measures of the variables: Age, improvement 









Mean 60,35 36,31 11,10
SD 9,93 25,72 8,79
Minimum 43,00 1,47 1,00




Mean 41,60 40,58 14,60
SD 16,82 29,20 11,27
Minimum 22,00 -4,60 2,00
Maximum 72,00 93,33 30,00
Total
Mean 52,31 38,14 12,60
SD 16,13 26,93 9,93
Minimum 22,00 -4,60 1,00
Maximum 76,00 100,00 30,00
Table 2 depicts the mean values of the speech re-
cognition index (SRI) throughout time, with their respective 
standard deviation and maximum and minimum values. 
The fundus of the eye exam only proved altered in 
four patients of the sample and they all belonged to the 
group with associated disease. Three patients were hyper-
tensive and diabetic, and one was only diabetic, in all the 
patients the alterations were mild diabetic retinopathies, 
characterized by the presence of retina microaneurysms. 
Table 3 depicts MRI alterations found for both groups.
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In the group with associated disease, 12 patients 
were hypertensive, two diabetics and three with dyslipi-
demias. In three patients there was association between 
arterial hypertension and diabetes mellitus. 
In the evaluation of the patients, 83% had tinnitus, 
51% had dizziness and 20% of the patients in our sample 
had ear fullness. And in the subsequent follow up of the 
patients we identified the recurrence of the sudden idio-
pathic sensorineural hearing loss in two patients from the 
group of patients with associated disease, the recurrence 
happened after six months of follow up. 
In Fig.1 we see the mean values of speech recog-
nition index (SRI) in the two groups along time. 
In order to compare the two groups studied in rela-
tion to the categorical variables belonging to the study we 
used the Fisher’s exact test. The results depicted on Table 
4 let us state that the groups “with associated disease” and 
“without associated disease” differ as to the result from 
the magnetic resonance imaging study.
In order to compare the two groups studied in re-
lation to variables Age, Improvement rate and Treatment 
onset time we used the t Student for non-related samples. 
The results depicted on Table 5 let us state that groups 
“with associated disease” and “without associated disease” 
differ as to the mean age. 
In order to study the behavior of the speech recog-
nition index (SRI) variable throughout time, in each group, 
Table 2. SRI variable values along time, according to each group 
and in relation to the total number of patients assessed in the study. 






Mean 21,60 34,32 40,00 44,42
SD 27,33 40,47 40,90 39,71
Minimum 0,00 0,00 0,00 0,00





Mean 17,60 44,62 53,87 59,73
SD 28,07 43,48 38,12 39,84
Minimum 0,00 0,00 0,00 0,00
Maximum 84,00 100,00 100,00 100,00
Total
Mean 19,89 38,50 45,94 51,18
SD 27,31 41,34 39,77 39,91
Minimum 0,00 0,00 0,00 0,00
Maximum 84,00 100,00 100,00 100,00









Normal 9 13 22
Microangiopathy 11 2 13
Total 20 15 35
Figure 1. Mean values of the SRI variable for each study group.
Table 4. Results from the comparison of the groups according to the 









Table 5. Results from the comparison between the two groups in 
relation to the numerical variables of the study. 
Variable Descriptive level
Age  0.001*
Improvement rate (%) 0.650
Treatment onset time 0.309
*p≤ 0,05
Table 6. Results from the application of the variance analysis model 
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we used the variance analysis model with repeated measu-
res. The results shown on Tables 6 and 7 let us state that:
For the group “with associated diseases”, the mean 
values obtained from 30 and 180 days are equal, but 
different from the mean value found in the beginning of 
the study. 
For the group “without associated disease”, we 
recorded a change in the mean values obtained with 
15, 30 and 180 days (which are equal) in relation to the 
initial value. 
difference concerning sudden idiopathic sensorineural 
hearing loss between men and women, according to the 
literature2. Initially, the men and women of the sample 
were analyzed separately, however, since there were no 
statistical differences between the results, the patients were 
grouped and assessed together. 
In our study we assessed the presence of symptoms 
such as tinnitus, dizziness and ear fullness. The prevalence 
of tinnitus was 83%, dizziness was 51% and ear fullness 
was present in 20% of our patients1,11. In the isolate asses-
sment of the groups with and without associated disease, 
regarding the presence of these symptoms, there were 
no statistically significant differences between the groups 
and without influence in the auditory recovery with the 
presence of tinnitus, dizziness and ear fullness. Our fin-
dings show the prevalence of these symptoms, however 
without worsening in hearing prognosis in both groups. 
In the patients “with associated disease”, systemic 
arterial hypertension was the most prevalent, followed by 
Dyslipidemia and diabetes mellitus. In three patients there 
was an association with systemic arterial hypertension and 
diabetes mellitus. In the study by Duck et al.12, evaluating 
the association of arterial hypertension with diabetes melli-
tus and in the studies by Morizono and Paparella13 and 
by Yan-Lin and Yuan-Ping14, evaluating the association of 
arterial hypertension with dyslipidemias, the association 
of these systemic diseases had an addictive effect on the 
worsening of the hearing loss. In our three patients, when 
evaluated alone, it was not possible to confirm this effect. 
In a more detailed evaluation we found that of 
the four patients with alterations in the fundus of the 
eye exams in the group of associated diseases, three had 
association with hypertension and diabetes and the other 
patient had only diabetes. Jorgensen and Buch15 found 
hearing loss, twice more common in diabetic patients with 
retinopathy. Axelsson et al.16 suggested the association of 
eye microangiopathies which happened in diabetes with 
different types of hearing loss, and Kurien et al.17 also ob-
served that the lack of diabetes control, assessed through 
eye complications, were important in the evolution of 
the hearing loss. Assessing again each one of the patients 
alone it was not possible to identify the relationship be-
tween ocular alterations of the eye fundus and the worst 
auditory evolution of the patients. Nonetheless, dealing 
specifically with sudden idiopathic sensorineural hearing 
loss the findings from Wilson et al.18 confirmed our results 
since they did not find such association as well. 
As we continued to assess the patients, we found 
that the age of the group with associated disease is sta-
tistically higher in the group without associated disease. 
In their study, Axelsson et al.19 had already described a 
worsening in the hearing loss with aging without, however, 
finding an association with diabetes control and duration. 
Brohem et al.20 studied hypertensive patients complaining 
Table 7. Results from the comparison between the measures obtai-
ned from the SRI at different instances, according to each group. 
Group Times compared Descriptive level
With disease Onset x 15 0.375
Onset x 30  0.029*
Onset x 180  0.001*
15 x 30 0.999
15 x 180 0.999
30 x 180 0.999
Without disease Onset x 15  0.001*
Onset x 30  0.001*
Onset x 180  0.001*
15 x 30 0.999
15 x 180 0.999
30 x 180 0.999
*p≤ 0,05
DISCUSSION
When describing two cases of sudden idiopathic 
sensorineural hearing loss in patients with diabetes, 
Jorgensen et al.9 suggested that the vascular alterations 
which happened as complications of diabetes would also 
involve inner ear vessels, which would explain the etio-
logy of sudden idiopathic sensorineural hearing loss in 
diabetic patients. Nonetheless, so far, the role of diabetes 
mellitus, systemic arterial hypertension and dyslipidemias 
in cases of sudden idiopathic sensorineural hearing loss 
remain unexplained1,10. The role of these disorders in the 
evolution and prognosis of patients with sudden idiopathic 
sensorineural hearing loss was the motivation we had for 
this study. 
In our study, the sample size was reduced because 
of our strict inclusion and exclusion criteria. Nevertheless, 
it was the only way to assess the evolution of patients with 
sudden idiopathic hearing loss in the presence of systemic 
arterial hypertension, diabetes mellitus and/or dyslipide-
mias throughout time, and not only to assess the hearing 
improvement with the treatment adopted. 
In our studies there was no statistically significant 
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of hearing usually associated to their more advanced age. 
Marchiori et al.21 considered systemic arterial hypertension 
and advanced age as isolated risk factors for sensorineural 
hearing loss. Concerning sudden idiopathic sensorineural 
hearing loss we could not isolate the most advanced age 
as an isolated risk, since the most advanced age coexisted 
in patients with associated diseases. 
In the hearing improvement evolution in patients 
with sudden idiopathic sensorineural hearing loss, the 
findings from Yamamoto et al.22 and Penido et al.1, were 
assessed through the hearing improvement rate and its 
results, with an auditory recovery above 50%, which were 
71.9% and 67.5% respectively. In our two groups, the 
mean values of the improvement rate are around 40% and 
without statistical difference between the groups, although 
we noticed a trend towards a better evolution for the group 
without associated disease. Both values contradict literature 
results; nonetheless, we must consider that for the group 
with associated disease and the group without associated 
disease the mean time of treatment onset was of 11 and 
15 days, respectively. Such values justify the worsening in 
the improvement rates, since in the two reported studies1,22 
the best results were obtained with the treatment onset 
in up to seven days after the onset of sudden idiopathic 
sensorineural hearing loss symptoms. 
Still in the auditory improvement evolution, Barros 
and tal.12 concluded that the speech recognition index 
could provide data as to sudden idiopathic hearing loss. 
This is confirmed in the evaluation of our patients, when 
the speech recognition index in both groups presented a 
statistically significant difference regarding evolution and in 
the interaction between the different assessment periods. 
In the group of associated disease, the improvement in the 
speech recognition index was more relevant on the first 
30 days after treatment onset while in the group without 
associated disease only the first fifteen days were the most 
relevant. This data shows a slower improvement in the 
group of patients with associated disease. 
In following the patients with sudden hearing loss 
along time, Furuhashi et al.8 studied 1798 patients who had 
sudden sensorineural hearing loss between the years of 
1972 and 2000, and found only 4 cases of ipsilateral recur-
rence (0.22%) and 10 of contralateral involvement (0.55%), 
with a time between the episodes varying between nine 
months and 14 years. In our study we found recurrence in 
the group with associated disease, nevertheless there were 
two cases of ipsilateral recurrence (10% of the group and 
5.7% of the sample) with more than six months and one 
year of time between the episodes. This data suggests the 
importance of the associated diseases in the evolution and 
prognosis of sudden idiopathic sensorineural hearing loss. 
The inner ear evaluation of the patients could 
provide more data than interfere in the evolution of our 
patients. In autopsies of diabetic patients, Makishima and 
Tanaka23 carried out a histopathology study of the temporal 
bones and found alterations, especially in the peripheral 
nerves, characterized by fibrous thickening and narrowing 
of the stria vascularis vessel lumen. The same histological 
findings were found by Smith et al.24 studying diabetic rats. 
Bachor et al.25, also doing histological studies of temporal 
bones, concluded that, in some cases the inner ear vas-
cular variation can be associated with hearing alterations. 
Nonetheless, the histopathology exam in our study was 
not possible to be carried out because it was not possible 
to collect in vivo material. Thus, the evaluation of the 
labyrinthine alterations and that of the central nervous 
system was based on MRI. 
In the assessment of patients with sudden idiopathic 
sensorineural hearing loss, Ramos et al.26 found alterations 
in the MRI of 46.9% of the patients, and the subcortical 
and hypertensive periventricular lesions - matching those 
of cerebral microangiopathy, represented 68.4% of the 
central alterations affecting patients which mean age was 
65.2 years. In a histopathological study with hypertensive 
rats, Junker et al.27 also found cerebral microangiopathy 
in regions already affected by hypertension. In our study, 
MRI also showed the presence of cerebral microangiopathy 
in 13 patients (37.14%) of the sample and proved to be 
more prevalent in the group  with associated disease (85% 
of the total), with a statistical difference. The two patients 
from the group without associated diseases (15%) with 
microangiopathy had ages above 65 years, which did not 
necessarily happen in the group with associated disease. 
This data shows the role age and associated diseases play 
in cerebral microangiopathy in the patients with sudden 
idiopathic sensorineural hearing loss. 
CONCLUSION
Sudden idiopathic sensorineural hearing loss in the 
presence of systemic arterial hypertension, diabetes melli-
tus and dyslipidemias, in older individual, is associated to 
a higher prevalence of cerebral microangiopathy in the 
MRI and it is implied in an auditory recovery with a slower 
evolution in the speech recognition index. 
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